BlackRock Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BIT
BFA
BlackRock Group's BMY Position: Q4 2016 in Review
BlackRock Group reduced its Bristol-Myers Squibb (BMY) stake by 0.15% in Q4 2016, selling an estimated $1.24M and leaving 14,919,472 shares worth $872M. The position accounts for 0.42% of the portfolio, ranked #48.
BlackRock Group first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.07B in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.
- BlackRock Group held 14,919,472 shares of Bristol-Myers Squibb worth $872M as of Q4 2016.
- BlackRock Group sold 22,593 Bristol-Myers Squibb shares in Q4 2016, an estimated $1.24M.
- Bristol-Myers Squibb made up 0.42% of BlackRock Group's portfolio in Q4 2016, its #48 holding.
- BlackRock Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
- BlackRock Group's Bristol-Myers Squibb position peaked at $1.07B in Q2 2016.
- 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.